Weitai Medical-B (02235) announces its interim results, with the net loss attributable to the owners of the parent company narrowing by approximately 2.2927 million yuan, a decrease of 93.9% year-on-year.

Wisdom Finance News APP reports that Weitai Medical - B (02235) has announced its mid-term performance for 2025. The operating income is about 246 million yuan, a year-on-year increase of 63.1%; gross profit is about 127 million yuan, a year-on-year increase of 57.7%; the net loss attributable to owners of the parent company is about 2.2927 million yuan, a year-on-year narrowing of 93.9%; loss per share is 0.005 yuan.